bekhterevОбозрение психиатрии и медицинской психологии имени В.М.БехтереваV.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY2313-70532713-055XV. M. BEKHTEREV NATIONAL RESEARCH MEDICAL CENTER FOR PSYCHIATRY AND NEUROLOGY OF THE RUSSIAN FEDERATION MINISTRY OF HEALTH10.31363/2313-7053-2020-3-3-10bekhterev-456Research ArticleПРОБЛЕМНЫЕ СТАТЬИPROBLEM-S0LVING ARTICLESНовый подход к систематике психических заболеваний: точка опоры или точка зрения?New approach to mental disorders systematics: starting point or point of view?НезнановН. Г.NeznanovN. G.

Незнанов Николай Григорьевич—доктор медицинских наук, профессор, директор ФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России, заведующий кафедрой психиатрии и наркологии ПСПбГМУ им. И.П. Павлова

Санкт-Петербург

Saint-Petersburg

nezn@bekhterev.ruРукавишниковГ. В.RukavishnikovG. V.

Рукавишников Григорий Викторович—кандидат медицинских наук, научный сотрудник отделения эндокринологической психиатрии

Санкт-Петербург

Saint-Petersburg

grigory_v_r@mail.ruКасьяновЕ. Д.KaysanovE. D.

Касьянов Евгений Дмитриевич—аспирант, младший научный сотрудник отделения эндокринологической психиатрии

Санкт-Петербург

Saint-Petersburg

ohkasyan@yandex.ruЖиляеваТ. В.ZhilyaevaT. V.

Жиляева Татьяна Владимировна—кандидат медицинских наук, доцент кафедры психиатрии и медицинской психологии

Nizhnij Novgorod

bizet@inbox.ruМазоГ. Э.MazoG. E.

Мазо Галина Элевна—доктор медицинских наук, ученый секретарь, руководитель отделения эндокринологической психиатрии

Санкт-Петербург

Saint-Petersburg

galina-mazo@yandex.ruФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России; ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Минздрава РоссииРоссияV.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; I.P. Pavlov First Saint-Petersburg State Medical UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава РоссииРоссияV.M. Bekhterev National Medical Research Center for Psychiatry and NeurologyRussian FederationФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава РоссииРоссияFederal State Budgetary Educational Institution of Higher Education Privolzhsky Research Medical University of Russian Ministry of HealthcareRussian Federation20201010202003310Copyright © Незнанов Н.Г., Рукавишников Г.В., Касьянов Е.Д., Жиляева Т.В., Мазо Г.Э., 20202020Незнанов Н.Г., Рукавишников Г.В., Касьянов Е.Д., Жиляева Т.В., Мазо Г.Э.Neznanov N.G., Rukavishnikov G.V., Kaysanov E.D., Zhilyaeva T.V., Mazo G.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.bekhterevreview.com/jour/article/view/456

Поиск новых подходов к классификации психических заболеваний—одна из приоритетных задач современной психиатрии. Предложенные на сегодняшний день подходы рассматривают психические нарушения изолированно, игнорируя тот факт, что психические расстройства—это мультисистемная патология, которая, кроме психических симптомов, затрагивает широкий спектр соматических проявлений. В настоящее время появляется все больше оснований рассматривать психические расстройства как мультисистемные заболевания. Такой подход представляет интерес не только для объяснения высокой коморбидности соматических и психических нарушений, но и в изучении патофизиологических механизмов, определяющих формирование и течение мультисистемных заболеваний. Данный путь может быть базисом для формирования принципиально новых подходов к систематике психических расстройств, имеющих как теоретическое, так и практическое значение. Для реализации такого подхода необходимо определить «точку опоры», которой может быть изучение связи психических расстройств с наследственными болезнями обмена.

The search for new approaches to the mental disordersclassification is one of the priority tasks in modern psychiatry. Current approaches evaluate mental disorders in isolation, ignoring the fact that they are a multisystem pathology that affects not only mental functions, but also a wide range of somatic manifestations. However, there is more and more reason to consider mental disorders as multisystem diseases. This approach is of interest not only for explaining the high comorbidity of somatic and mental disorders, but also in studying the pathophysiological mechanisms that determine the risks and course of multisystem diseases. This strategy can be the basis for the fundamentally new approaches to the systematics of mental disorders with both theoretical and practical significance. To integratesuch an approach, it is necessary to determine the “starting point”, which may be the evaluation of mental disorders andinherited metabolic disorders interaction.

психические расстройствасистематиканаследственные болезни обменамультисистемные заболеванияmental disorderssystematicsinherited metabolic disordersmultisystem diseasesРабота выполнена при поддержке гранта РФФИ № 19-015-00420 А.ReferencesНезнанов Н.Г. Депрессия и риск развития соматических заболеваний Руководство для врачей. Под ред. Н.Г. Незнанова, Г.Э. Мазо, А.О. Кибитов. Москва: Специальное издательство медицинских книг. 2019: 248 c.Neznanov N.G. Depressiya i risk razvitiya somaticheskih zabolevanij Rukovodstvo dlya vrachej. Pod red. N.G. Neznanova, G.E. Mazo, A.O. Kibitov. Moskva: Special’noe izdatel’stvo medicinskih knig. 2019:248. (In Russ.).Незнанов Н.Г., Козлова С.Н., Мазо Г.Э., Шляхто Е.В., Смирнов Б.И. Коморбидность депрессивных расстройств и ишемической болезни сердца: общие аспекты патогенеза. Журнал неврологии и психиатрииим. С.С. Корсакова. 2015; 115(5):20-26. doi: 10.17116/jnevro20151155120-26Neznanov NG, Kozlova SN, Mazo GE, Shlyakhto NG, Smirnov BI. Comorbidity of depressive disorders and coronary heart disease: general aspects of pathogenesis. Zhurnal Nevrologii I Psikhiatrii im. S.S. Korsakova. 2015; 115(5):20-26 (In Russ.). doi: 10.17116/jnevro20151155120-26Рукавишников Г.В., Кибитов А.О., Мазо Г.Э., Незнанов Н.Г. Генетическая детерминированность коморбидности депрессии и соматических заболеваний. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019; 119(1):89-96. doi: 10.17116/jnevro201911901189Rukavishnikov GV, Kibitov AO, Mazo GE, Neznanov NG. Genetic comorbidity of depression and somatic disorders. Zhurnal Nevrologii I Psikhiatrii im. S.S. Korsakova. 2019; 119(1):89-96. (In Russ.). doi: 10.17116/jnevro201911901189Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress. Anxiety. 2009; 26(7):607– 611. doi: 10.1002/da.20589Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress. Anxiety. 2009; 26(7):607– 611. doi: 10.1002/da.20589Arends M, van Dussen L, Biegstraaten M, Hollak CE. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature. Br J Haematol. 2013; 161(6):832–842. doi:10.1111/bjh.12335Arends M, van Dussen L, Biegstraaten M, Hollak CE. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature. Br J Haematol. 2013; 161(6):832–842. doi:10.1111/bjh.12335Baeza-Velasco C, Pailhez G, Bulbena A, Bagh- dadli A. Joint hypermobility and the heritable dis- orders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry. 2015; 37(1):24–30. doi:10.1016/j.genhosppsych.2014.10.002Baeza-Velasco C, Pailhez G, Bulbena A, Bagh- dadli A. Joint hypermobility and the heritable dis- orders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry. 2015; 37(1):24–30. doi:10.1016/j.genhosppsych.2014.10.002Clark LA, Cuthbert B, Lewis-Fernández R et al. Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health’s Research Domain Criteria (RDoC). Psychol Sci Public Interest. 2017; 18:72-145. doi: 10.1177/1529100617727266Clark LA, Cuthbert B, Lewis-Fernández R et al. Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health’s Research Domain Criteria (RDoC). Psychol Sci Public Interest. 2017; 18:72-145. doi: 10.1177/1529100617727266Conway CC, Forbes MK, Forbush KT, et al. A Hierarchical Taxonomy of Psychopathology Can Transform Mental Health Research. PerspectPsychol Sci. 2019; 14(3):419–436. doi:10.1177/1745691618810696Conway CC, Forbes MK, Forbush KT, et al. A Hierarchical Taxonomy of Psychopathology Can Transform Mental Health Research. PerspectPsychol Sci. 2019; 14(3):419–436. doi:10.1177/1745691618810696Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3, 211, 768 patients and 113, 383, 368 controls. World Psychiatry. 2017; 16:163–80. doi: 10.1002/wps.20420Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3, 211, 768 patients and 113, 383, 368 controls. World Psychiatry. 2017; 16:163–80. doi: 10.1002/wps.20420Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013; 170:324–33. doi: 10.1176/appi.ajp.2012.12050599Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013; 170:324–33. doi: 10.1176/appi.ajp.2012.12050599Cuthbert BN, Kozak MJ. Constructing constructs for psychopathology: the NIMH research domain criteria. J Abnorm Psychol. 2013; 122(3):928–937. doi:10.1037/a0034028Cuthbert BN, Kozak MJ. Constructing constructs for psychopathology: the NIMH research domain criteria. J Abnorm Psychol. 2013; 122(3):928–937. doi:10.1037/a0034028Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014; 13:27. doi:10.1186/s12991-014-0027-xDemily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014; 13:27. doi:10.1186/s12991-014-0027-xDipple KM, McCabe ER. Phenotypes of patients with «simple» Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet. 2000; 66(6):1729–1735. doi:10.1086/302938Dipple KM, McCabe ER. Phenotypes of patients with «simple» Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet. 2000; 66(6):1729–1735. doi:10.1086/302938Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis. 2000; 23(1):2–6. doi:10.1023/a:1005685010766Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis. 2000; 23(1):2–6. doi:10.1023/a:1005685010766Fusar-Poli P., Solmi M., Brondino N., Davies C., Chae C., Politi P., Borgwardt S., Lawrie SM, Parnas J, McGuire P. Transdiagnostic psychiatry: a systematic review. World Psychiatry. 2019; 18(2):192–207. doi: 10.1002/wps.20631Fusar-Poli P., Solmi M., Brondino N., Davies C., Chae C., Politi P., Borgwardt S., Lawrie SM, Parnas J, McGuire P. Transdiagnostic psychiatry: a systematic review. World Psychiatry. 2019; 18(2):192–207. doi: 10.1002/wps.20631Ganesh S, Ahmed P H, Nadella RK, et al. Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes. Psychiatry ClinNeurosci. 2019; 73(1):11–19. doi:10.1111/pcn.12788Ganesh S, Ahmed P H, Nadella RK, et al. Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes. Psychiatry ClinNeurosci. 2019; 73(1):11–19. doi:10.1111/pcn.12788Herrera PM, Vélez Van Meerbeke A, Bonnot O. Psychiatric Disorders Secondary to Neurometabolic Disorders. Trastornospsiquiátricossecundariosaenfermedadesneurometabólicas. Rev ColombPsiquiatr. 2018; 47(4):244–251. doi:10.1016/j.rcp.2017.05.004Herrera PM, Vélez Van Meerbeke A, Bonnot O. Psychiatric Disorders Secondary to Neurometabolic Disorders. Trastornospsiquiátricossecundariosaenfermedadesneurometabólicas. Rev ColombPsiquiatr. 2018; 47(4):244–251. doi:10.1016/j.rcp.2017.05.004Jinnah HA, Sabina RL, Van Den Berghe G. Metabolic disorders of purine metabolism affecting the nervous system. HandbClin Neurol. 2013; 113:1827–1836. doi:10.1016/B978-0-444-59565-2.00052-6Jinnah HA, Sabina RL, Van Den Berghe G. Metabolic disorders of purine metabolism affecting the nervous system. HandbClin Neurol. 2013; 113:1827–1836. doi:10.1016/B978-0-444-59565-2.00052-6Johnstone EC, Cooling NJ, Frith CD, Crow TJ, Owens DG. Phenomenology of organic and func- tional psychoses and the overlap between them. Br J Psychiatry. 1988; 153:770–776. doi:10.1192/bjp.153.6.770Johnstone EC, Cooling NJ, Frith CD, Crow TJ, Owens DG. Phenomenology of organic and func- tional psychoses and the overlap between them. Br J Psychiatry. 1988; 153:770–776. doi:10.1192/bjp.153.6.770Kamens SR, Robbins BD, Flanagan EH. Introduction to the Special Issues on Diagnostic Alternatives. Journal of Humanistic Psychology. 2017: 57(6):567–572. doi: 10.1177/0022167817701253Kamens SR, Robbins BD, Flanagan EH. Introduction to the Special Issues on Diagnostic Alternatives. Journal of Humanistic Psychology. 2017: 57(6):567–572. doi: 10.1177/0022167817701253Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl. 1996; 30:17–30.Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl. 1996; 30:17–30.Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011; 6(9):e24597. doi:10.1371/journal.pone.0024597Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011; 6(9):e24597. doi:10.1371/journal.pone.0024597Maes M, Leonard B, Fernandez A, et al. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. ProgNeuropsychopharmacolBiol Psychiatry. 2011; 35(3):659–663. doi:10.1016/j.pnpbp.2011.02.019Maes M, Leonard B, Fernandez A, et al. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. ProgNeuropsychopharmacolBiol Psychiatry. 2011; 35(3):659–663. doi:10.1016/j.pnpbp.2011.02.019Maj M. Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them. World Psychiatry. 2018; 17(2):121-122.doi:10.1002/wps.20512Maj M. Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them. World Psychiatry. 2018; 17(2):121-122.doi:10.1002/wps.20512Manouilenko I, Eriksson JM, Humble MB, Bejerot S. Minor physical anomalies in adults with autism spectrum disorder and healthy controls. Autism Res Treat. 2014; 2014:743482. doi:10.1155/2014/743482Manouilenko I, Eriksson JM, Humble MB, Bejerot S. Minor physical anomalies in adults with autism spectrum disorder and healthy controls. Autism Res Treat. 2014; 2014:743482. doi:10.1155/2014/743482McAllister-Williams RH, Anderson IM, Finkelmeyer A, et al. and the ADD Study Team. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet Psychiatry. 2015; 3(2):117-27. doi: 10.1016/S2215-0366(15)00436-8McAllister-Williams RH, Anderson IM, Finkelmeyer A, et al. and the ADD Study Team. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet Psychiatry. 2015; 3(2):117-27. doi: 10.1016/S2215-0366(15)00436-8Millon T. Contemporary directions in psychopathology: scientific foundations of the DSM-V and ICD-11/ edited by T. Millon, R.F. Krueger, E. Simonsen. NY: The Guilford Press, 2010; 3-97:223- 242, 263-275.Millon T. Contemporary directions in psychopathology: scientific foundations of the DSM-V and ICD-11/ edited by T. Millon, R.F. Krueger, E. Simonsen. NY: The Guilford Press, 2010; 3-97:223- 242, 263-275.Mothi SS, Tandon N, Padmanabhan J, et al. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophr Res. 2015; 165(1):103–107. doi:10.1016/j.schres.2015.03.034Mothi SS, Tandon N, Padmanabhan J, et al. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophr Res. 2015; 165(1):103–107. doi:10.1016/j.schres.2015.03.034National Institute of Mental Health. Sensorimotor Domain Added to the RDoC Framework. January 14, 2019. Retrieved from: https://www.nimh.nih.gov/news/science-news/2019/sensorimotor-domainadded-to-the-rdoc-framework.shtmlNational Institute of Mental Health. Sensorimotor Domain Added to the RDoC Framework. January 14, 2019. Retrieved from: https://www.nimh.nih.gov/news/science-news/2019/sensorimotor-domainadded-to-the-rdoc-framework.shtmlPillinger T, D’Ambrosio E, McCutcheon R, Howes OD. Is psychosis a multisystem disorder? A metareview of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models [published correction appears in Mol Psychiatry. Mol Psychiatry. 2019; 24(6):776–794. doi:10.1038/s41380-018-0058-9Pillinger T, D’Ambrosio E, McCutcheon R, Howes OD. Is psychosis a multisystem disorder? A metareview of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models [published correction appears in Mol Psychiatry. Mol Psychiatry. 2019; 24(6):776–794. doi:10.1038/s41380-018-0058-9Reininghaus U, Böhnke JR, Chavez‐Baldini UY, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA and Tamminga CA. Transdiagnostic dimensions of psychosis in the Bipolar‐Schizophrenia Network on Intermediate Phenotypes (B‐SNIP). World Psychiatry. 2019; 18(1):67-76. doi: 10.1002/wps.20607Reininghaus U, Böhnke JR, Chavez‐Baldini UY, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA and Tamminga CA. Transdiagnostic dimensions of psychosis in the Bipolar‐Schizophrenia Network on Intermediate Phenotypes (B‐SNIP). World Psychiatry. 2019; 18(1):67-76. doi: 10.1002/wps.20607Salloum IM. Psychiatric Diagnosis: Challenges and Prospects/ edited by Ihsan M. Salloum and Juan E. Mezzich. UK: John Wiley & Son. 2009; 1-29: 187-213, 219-262.Salloum IM. Psychiatric Diagnosis: Challenges and Prospects/ edited by Ihsan M. Salloum and Juan E. Mezzich. UK: John Wiley & Son. 2009; 1-29: 187-213, 219-262.Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007; 30(5):631–641. doi:10.1007/s10545-007-0661-4Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007; 30(5):631–641. doi:10.1007/s10545-007-0661-4Sidransky E. Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin Genet. 2006; 70(4):275–282. doi:10.1111/j.1399-0004.2006.00688.xSidransky E. Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin Genet. 2006; 70(4):275–282. doi:10.1111/j.1399-0004.2006.00688.xStegink LD, Koch R, Blaskovics ME, Filer LJ Jr, Baker GL, McDonnell JE. Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/ kg body weight. Toxicology. 1981; 20(1):81–90. doi:10.1016/0300-483x(81)90108-6Stegink LD, Koch R, Blaskovics ME, Filer LJ Jr, Baker GL, McDonnell JE. Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/ kg body weight. Toxicology. 1981; 20(1):81–90. doi:10.1016/0300-483x(81)90108-6Tishler PV, Woodward B, O’Connor J, et al. High prevalence of intermittent acute porphyria in a psychiatric patient population. Am J Psychiatry. 1985; 142(12):1430–1436. doi:10.1176/ajp.142.12.1430Tishler PV, Woodward B, O’Connor J, et al. High prevalence of intermittent acute porphyria in a psychiatric patient population. Am J Psychiatry. 1985; 142(12):1430–1436. doi:10.1176/ajp.142.12.1430Van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016; 15(2):118-24. doi: 10.1002/wps.20310Van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016; 15(2):118-24. doi: 10.1002/wps.20310Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007; 33(4):886–892. doi:10.1093/schbul/sbm057Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007; 33(4):886–892. doi:10.1093/schbul/sbm057Vockley J. Metabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseases. J Inherit Metab Dis. 2008; 31(5):619–629. doi:10.1007/s10545-008-1005-8Vockley J. Metabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseases. J Inherit Metab Dis. 2008; 31(5):619–629. doi:10.1007/s10545-008-1005-8Weinberg SM, Jenkins EA, Marazita ML, Maher BS. Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr Res. 2007; 89(1-3):72–85. doi:10.1016/j.schres.2006.09.002Weinberg SM, Jenkins EA, Marazita ML, Maher BS. Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr Res. 2007; 89(1-3):72–85. doi:10.1016/j.schres.2006.09.002Xu T, Chan RC, Compton MT. Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis. PLoS One. 2011; 6(9):e24129. doi:10.1371/journal.pone.0024129Xu T, Chan RC, Compton MT. Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis. PLoS One. 2011; 6(9):e24129. doi:10.1371/journal.pone.0024129Zajecka JM, Fava M, Shelton RC, Barrentine LW, Young P, Papakostas GI. Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors. The Journal of Clinical Psychiatry. 2016; 77(5):654–660. doi:10.4088/jcp.15m10181Zajecka JM, Fava M, Shelton RC, Barrentine LW, Young P, Papakostas GI. Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors. The Journal of Clinical Psychiatry. 2016; 77(5):654–660. doi:10.4088/jcp.15m10181

The authors declare that there are no conflicts of interest present.